Cohesion Technologies Invites You to Join Its Third Quarter Conference Call on the Web

Apr 18, 2001, 01:00 ET from Cohesion Technologies, Inc.

    SAN FRANCISCO, April 18 /PRNewswire/ -- In conjunction with
 Cohesion Technologies, Inc.'s (Nasdaq:   CSON) Third Quarter earnings
 release, you are invited to listen to its conference call that will be
 broadcast live over the Internet on Monday, April 23, 2001 at 1:30 p.m.
 PACIFIC (4:30 p.m. EASTERN).
 
     What:   Cohesion Technologies, Inc. Fiscal 2001
             Third Quarter Earnings Conference Call
 
     When:   Monday, April 23, 2001, 1:30 p.m. PACIFIC (4:30 p.m. EASTERN)
 
     Where:  http://www.videonewswire.com/COHESION/042301/
 
     How:    Live over the Internet -- Simply log on to the web at the address
             above
 
     Contact:  Lisa Morgensai, 650-320-5633, lmorgensai@cson.com
 
     Cohesion Technologies, Inc. discovers, develops and commercializes
 innovative resorbable biodevices, adhesive technologies and delivery systems
 in the fields of tissue repair and regeneration. Cohesion is currently
 developing and commercializing products for the estimated $1.5 billion
 worldwide emerging market for BioSurgical materials.
     In addition to a rich product pipeline based on multiple technology
 platforms in synthetic polymers, collagen and thrombin, and autologous plasma,
 Cohesion is currently launching two products:  CoStasis(R) surgical hemostat,
 a liquid sprayable hydrogel designed for use as an adjunct to hemostasis in
 surgical procedures, except neurological, ophthalmic and urological surgeries.
 CoStasis is marketed in the U.S., Europe and select countries.  CoSeal(TM)
 surgical sealant, a resorbable synthetic, self-polymerizing gel used for
 sealing around vascular reconstructions and vascular incision lines to prevent
 the leakage of blood.  CoSeal is marketed in Europe and select countries
 outside the U.S.  Cohesion recently filed a premarket approval ("PMA")
 application with the U.S. FDA for CoSeal.  For more information about Cohesion
 Technologies, its products and its research and development activities, please
 visit the Company's web site at www.cohesiontech.com.
     If you are unable to participate during the live webcast, the call will be
 archived on Cohesion's web site at www.cohesiontech.com through Friday,
 April 27, 2001.
     Please note:  Minimum Requirements to listen to broadcast:  The RealPlayer
 software, downloadable free from www.real.com/products/player/index.html, and
 at least a 14.4Kbps connection to the Internet.  If you experience problems
 listening to the broadcast, send an email to webmaster@vdat.com.
 
 

SOURCE Cohesion Technologies, Inc.
    SAN FRANCISCO, April 18 /PRNewswire/ -- In conjunction with
 Cohesion Technologies, Inc.'s (Nasdaq:   CSON) Third Quarter earnings
 release, you are invited to listen to its conference call that will be
 broadcast live over the Internet on Monday, April 23, 2001 at 1:30 p.m.
 PACIFIC (4:30 p.m. EASTERN).
 
     What:   Cohesion Technologies, Inc. Fiscal 2001
             Third Quarter Earnings Conference Call
 
     When:   Monday, April 23, 2001, 1:30 p.m. PACIFIC (4:30 p.m. EASTERN)
 
     Where:  http://www.videonewswire.com/COHESION/042301/
 
     How:    Live over the Internet -- Simply log on to the web at the address
             above
 
     Contact:  Lisa Morgensai, 650-320-5633, lmorgensai@cson.com
 
     Cohesion Technologies, Inc. discovers, develops and commercializes
 innovative resorbable biodevices, adhesive technologies and delivery systems
 in the fields of tissue repair and regeneration. Cohesion is currently
 developing and commercializing products for the estimated $1.5 billion
 worldwide emerging market for BioSurgical materials.
     In addition to a rich product pipeline based on multiple technology
 platforms in synthetic polymers, collagen and thrombin, and autologous plasma,
 Cohesion is currently launching two products:  CoStasis(R) surgical hemostat,
 a liquid sprayable hydrogel designed for use as an adjunct to hemostasis in
 surgical procedures, except neurological, ophthalmic and urological surgeries.
 CoStasis is marketed in the U.S., Europe and select countries.  CoSeal(TM)
 surgical sealant, a resorbable synthetic, self-polymerizing gel used for
 sealing around vascular reconstructions and vascular incision lines to prevent
 the leakage of blood.  CoSeal is marketed in Europe and select countries
 outside the U.S.  Cohesion recently filed a premarket approval ("PMA")
 application with the U.S. FDA for CoSeal.  For more information about Cohesion
 Technologies, its products and its research and development activities, please
 visit the Company's web site at www.cohesiontech.com.
     If you are unable to participate during the live webcast, the call will be
 archived on Cohesion's web site at www.cohesiontech.com through Friday,
 April 27, 2001.
     Please note:  Minimum Requirements to listen to broadcast:  The RealPlayer
 software, downloadable free from www.real.com/products/player/index.html, and
 at least a 14.4Kbps connection to the Internet.  If you experience problems
 listening to the broadcast, send an email to webmaster@vdat.com.
 
 SOURCE  Cohesion Technologies, Inc.